title: FK 506 in the management of nephrotic syndrome after renal transplantation.
authors.affiliation: Transplantation Institute, University of Pittsburgh, PA.
authors.forename: J
authors.initials: J
authors.lastname: McCauley
authors.forename: R
authors.initials: R
authors.lastname: Shapiro
authors.forename: M
authors.initials: M
authors.lastname: Jordan
authors.forename: V
authors.initials: V
authors.lastname: Scantlebury
authors.forename: C
authors.initials: C
authors.lastname: Vivas
authors.forename: C
authors.initials: C
authors.lastname: Jensen
authors.forename: T E
authors.initials: TE
authors.lastname: Starzl
mesh_terms: D001379:Azathioprine / Q000627:therapeutic use; D001706:Biopsy; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection / Q000175:diagnosis; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology* / Q000502:physiology; D009404:Nephrotic Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D010865:Pilot Projects; D011183:Postoperative Complications / Q000188:drug therapy; D011241:Prednisone / Q000627:therapeutic use; D011507:Proteinuria; D016559:Tacrolimus / Q000627:therapeutic use*; D014184:Transplantation, Homologous
chemical_list: D016572:Cyclosporine; D003404:Creatinine; D001379:Azathioprine; D011241:Prednisone; D016559:Tacrolimus